Pfizer’s cough syrup Corex top brand; Cipla no.1 company in India during 2009: ORG IMS

Cough medication Corex by Pfizer has emerged the top selling brand in India with annual sales of Rs 182 crore during the year 2009, according to Stockist Secondary Audit data from drug sales tracking agency, ORG-IMS India.

Stockist Secondary Audit is an audit which tracks the stockist sales to the retailer i.e. secondary sales.

ORG IMS has a panel of more than 3,500 stockists who cater to more than 50,000 retailers all across the country.

India’s domestic pharmaceutical market is currently valued at Rs 40,051.74 crore, an increase of 17 per cent over the previous year.

Among the players, the Mumbai-based Cipla with a product portfolio of 924 drugs retained its position as the number one company in India.

Daiichi-controlled Ranbaxy and the Indian arm of the global drug giant GlaxoSmithKline came second and third positions with drug product baskets of 565 and GSK’s 177 products respectively.

Cipla’s market share grew 18 per cent during the year 2009. Ranbaxy enjoys a market share of 4.91 per cent with a growth of 13.7 per cent while GSK had a market share of 4.35 per cent,   18 per cent growth rate in 2009.

Cipla registered sales of Rs 2,155.29 crore in the Indian market, much ahead of Ranbaxy’s Rs 1,968.24 crore and GSK’s Rs 1,743.15 crore sales during 2009.

Cipla had overtaken Ranbaxy and GSK India to become the largest pharmaceutical company in Indian market in May, 2007, reports said.

Piramal Health with product kitty of 750 drugs finished fourth with a 4.11% market share and Rs 1644 crore sales. Ahmedabad-based Zydus Cadila and Sun Pharma of Mumbai occupied 5th and 6th slots 735 and 516 products and less than four percent market shares. Zydus Cadila’s Indian sales grew over 21% to Rs 1484 crore while Sun Pharma’s sales revenues touched nearly 23%  growth to Rs 1449 crore in 2009 compared to sales a year ago.

Alkem Laboratories, Mankind, Lupin and Aristo Pharma are other players in the top ten segment that came 7th to 10th positions.

Elder Pharma, a mid-size firm from Mumbai, emerged as the fastest growing company in the domestic market among the top 50 players, with a year-on-year (YoY) growth rate of 28.1 per cent over the previous year.

Elders surpassed the other fast-growing players including Mankind (27.9 per cent), Wanbury ( 25.2 per cent), Micro Labs and Alembic (24.7 per cent).

ORG IMS Indian Pharmaceutical Audit helps to identify potential therapeutic categories, monitoring performance of specific brands in relation to competing brands, segmenting the market by 4 zones, 18 states, 30 metros and all town classes.

IMS Indian Pharmaceutical Audit tracks the primary sales of pharmaceutical companies on monthly basis through stockists purchase.

The value growth of Indian pharma market as per secondary sales for the month of Dec’09 was recorded higher at 27.6% as compared to Nov’09 month (20.4%). The value growth for Dec’09 MAT was also recorded higher at 17.0%, as compared to 15.7% as per Nov’09 MAT.

The value growth recorded in the month of Dec’09 was higher at 17.0%, as compared to 9.1% in the month of Nov’09. The value growth as per Dec’09 MAT (13.0%) was comparable to Nov’09 MAT (13.1%)

Cipla has maintained its top position and market share of 5.38%, as per Dec’09 MAT,

Among the top 25 companies, Mankind has jumped one rank to move upto rank 8.Wockhardt Merind has jumped two ranks to move upto rank 14

In the month of Dec’09, among the top 20 companies, Novartis Intl has gained two ranks and moved up to rank 21 Wockhardt Merind (#17) and FDC (#19) have gained one rank each, according to ORG IMS sales data for the month of December 2009.

Indian domestic market has over 23,000 companies marketing more than 60,000 prescription brands.

At the super group level, cardio vascular system has recorded 19% value growth, followed by alimentary tract and metabolism with 18% growth and systemic anti-infectives has recorded 13% growth, in the month of December.

IMS Health and ACNielsen ORG-MARG entered into a joint venture on the 1st of January 2004, aligning their health care information business operations in India, bringing together the two organizations.

ACNielsen ORG-MARG is a leading solutions provider of syndicated and non-syndicated information services in India that examine health care, consumer products, financial, retail, business to business, and media performance trends. IMS is the world’s leading provider of information solutions to the pharmaceutical and healthcare industries.